Tergus Pharma, a topical contract development and manufacturing organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
 
The event featured speeches by North Carolina Gov. Roy Cooper, North Carolina Attorney General Josh Stein, NC Biotech Center president and CEO Doug Edgeton, and was attended by senior executives from Tergus Pharma, members of its board of directors, and other dignitaries.

In addition to corporate and administrative offices, the new Tergus facility houses research and development laboratories, in addition to six commercial GMP manufacturing suites, six filling and packaging suites, along with two dedicated High-Potent and Hormonal suites.
 
Tergus Pharma’s long-term vision in Research Triangle Park (Durham, NC) is to become the largest topical drug product contract development and manufacturing company in the United States. To realize this vision, Tergus is working closely with the state of North Carolina, the Durham Chamber of Commerce, and the NC Biotechnology Center.
 
“This event marks a significant turning point for us,” said Tergus Pharma chairman and CEO, Dr. Vijendra Nalamothu before the event. “And the growth spurred on by this facility will create new jobs and business opportunities for the counties of Durham, Wake, and the state of North Carolina. We are proud to be a part of the pharmaceutical success story here in the Triangle area of North Carolina.”